The United States and the world face a continued risk of chemical, biological, radiological, or nuclear attacks or a natural disease pandemic. Join BPC in a discussion about the importance of sustainable funding to develop and stockpile medical countermeasures (MCM) that are critical to our national security and public health emergency preparedness.
Join the discussion on Twitter: @BPC_Bipartisan #BPClive
Having trouble viewing the video player below? We recommend using either Google Chrome or Firefox as your internet browser. Archived footage of the discussion will be posted following the event.
Former U.S. Senate Majority Leader
Former Senator, South Dakota
Former Chairman, U.S. Senate Budget Committee
Former Senator, New Hampshire
Republican Staff Director, U.S. Senate Budget Committee
Democratic Staff Director, U.S. Senate Appropriations Committee
Managing Director, Infectious Diseases and Diagnostics Policy, Biotechnology Innovation Organization (BIO)
Rick Bright, Ph.D
Director, Biomedical Advanced Research and Development Authority (BARDA), U.S. Department of Health and Human Services